<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>HSCRP_J</title>
    <meta name="title" content="NHANES 2017-2018: High-Sensitivity C-Reactive Protein Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent Sequence Number</a>
              </li>
              <li>
                <a href="#LBXHSCRP">LBXHSCRP - HS C-Reactive Protein (mg/L)</a>
              </li>
              <li>
                <a href="#LBDHRPLC">LBDHRPLC - HS C-Reactive Protein Comment Code</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2017-2018 Data Documentation, Codebook, and Frequencies</h2>
        <h3>High-Sensitivity C-Reactive Protein (HSCRP_J)</h3>
        <h4> Data File: HSCRP_J.xpt</h4>
        <h5 class="left">First Published: February 2020</h5>
        <h5 class="right">Last Revised: NA</h5>
        <h5 class="specialnote">Note: See Analytic Note on Regression equations to compare 2017-2018 and 2015-2016 High-Sensitivity C-Reactive Protein data </h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">C-reactive protein
(CRP) is an acute phase protein synthesized in the liver. It is involved in the
activation of complement, enhancement of phagocytosis, and detoxification of
substances released from damaged tissue. It is one of the most sensitive,
though nonspecific, indicators of inflammation. CRP levels may rise within six
hours of an inflammatory stimulus. Measurement of CRP concentrations by this
highly sensitive method is performed primarily to ascertain the level of
cardiovascular disease risk in individuals who have no existing inflammatory conditions.
Increases in CRP concentration are non-specific and should be used in
conjunction with traditional clinical laboratory evaluation of acute coronary
syndromes.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Examined
participants aged 1 year and older were eligible. </p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This is a
two-reagent, immunoturbidimetric system. The specimen is first combined with a
Tris buffer, then incubated. The second reagent (latex particles coated with
mouse anti-human CRP antibodies) is then added. In the presence of circulating
CRP the latex particles aggregate, forming immune complexes. These complexes
cause an increase in light scattering that is proportional to the CRP
concentration. The light absorbance resulting from this light scatter is read
against a stored CRP standard curve. The concentration of CRP is determined
from this line. Turbidity is measured at a primary wavelength of 546 nm
(secondary wavelength 800 nm).</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the
Laboratory Method Files section for a detailed description of the laboratory methods
used.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There were changes
to the lab method, lab equipment and lab site for this component in the NHANES 2017-2018
cycle. </p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HSCRP-J-MET-508.pdf">HS-CRP Laboratory Procedure Manual</a>
          <span> (February 2020)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Serum specimens
are processed, stored, and shipped to the University of Minnesota &ndash; Advanced
Research Diagnostics Laboratory (ARDL), Minneapolis, MN for analysis. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Detailed
instructions on specimen collection and processing are discussed in the NHANES <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">Laboratory
Procedures Manual (LPM)</a>. Vials were
stored under appropriate frozen (&ndash;30&deg;C) conditions until they were shipped to
Collaborative Laboratory Services for testing.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The NHANES quality
control and quality assurance protocols (QA/QC) meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the&nbsp;<a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">NHANES LPM</a>.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Mobile Examination Centers (MECs)</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Laboratory team performance is monitored using several
techniques. NCHS and contract consultants use a structured competency
assessment evaluation during visits to evaluate both the quality of the
laboratory work and the quality-control procedures. Each laboratory staff member
is observed for equipment operation, specimen collection and preparation;
testing procedures and constructive feedback are given to each staff member.
Formal retraining sessions are conducted annually to ensure that required skill
levels were maintained.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Analytical Laboratories</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">NHANES uses several methods to monitor the quality of the
analyses performed by the contract laboratories. In the MEC, these methods
include performing blind split samples collected during &ldquo;dry run&rdquo; sessions. In
addition, contract laboratories randomly perform repeat testing on 2% of all
specimens.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"> NCHS
developed and distributed a quality control protocol for all CDC and contract
laboratories, which outlined the use of Westgard rules (Westgard, et al., 1981)
when running NHANES specimens. Progress reports containing any problems
encountered during shipping or receipt of specimens, summary statistics for
each control pool, QC graphs, instrument calibration, reagents, and any special
considerations are submitted to NCHS quarterly. The reports are reviewed for
trends or shifts in the data. The laboratories are required to explain any
identified areas of concern. </p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The data were
reviewed. Incomplete data or improbable values were sent to the performing
laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017" target="_blank">2017-2018 Laboratory Data Overview </a>for general
information on NHANES laboratory data.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. For example, in 2017-2018, approximately 80% of children aged 1-17 years who were examined in the MEC provided a blood specimen through phlebotomy, while 95% of examined adults age 18 and older provided a blood specimen. Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Demographic and
Other Related Variables</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The analysis of NHANES laboratory data must be conducted
using the appropriate survey design and demographic variables. The <span style="color: #003399;"><a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2017" target="_blank">NHANES
2017-2018 Demographics File</a></span> contains demographic data, health
indicators, and other related information collected during household interviews
as well as the sample design variables. The recommended procedure for variance
estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU,
respectively) in the demographic data file.&nbsp;</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The<a href="https://wwwn.cdc.gov/nchs/nhanes/2017-2018/fastqx_j.htm" target="_blank"> Fasting Questionnaire
File</a>
includes auxiliary information, such as fasting status, length of fast and the
time of venipuncture.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This laboratory data file can be linked to the other NHANES
data files using the unique survey participant identifier (i.e., SEQN).</p>
&nbsp;
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Detection Limits</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The detection
limit was constant for the analyte in the data set. Two variables are provided
for this analyte. The variable name ending in &ldquo;LC&rdquo; (ex., LBDHRPLC) indicates
whether the result was below the limit of detection: the value &ldquo;0&rdquo; means that
the result was at or above the limit of detection, &ldquo;1&rdquo; indicates that the
result was below the limit of detection. For the analyte with analytic results
below the lower limit of detection (LBDHRPLC=1), an imputed fill value was
placed in the analyte results field. This value is the lower limit of detection
divided by square root of 2 (LLOD/sqrt [2]). The variable prefixed LBX (ex., LBXHSCRP)
provides the analytic result for that analyte.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The lower limit of
detection (LLOD, in mg/L) for High-Sensitivity C-Reactive Protein:</p>
<div style="text-align: center;">
<table width="0" style="border: currentColor; border-image: none; width: 438.3pt; border-collapse: collapse; mso-border-alt: solid black .75pt; mso-yfti-tbllook: 1184; mso-padding-alt: 1.5pt 1.5pt 1.5pt 1.5pt;" border="1" cellspacing="0" cellpadding="0">
    <tbody>
        <tr style="height: 14.1pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes;">
            <td style="background: #b8cce4; padding: 3.75pt; border: 1pt solid black; border-image: none; width: 116.6pt; height: 14.1pt; mso-border-alt: solid black .75pt; mso-background-themecolor: accent1; mso-background-themetint: 102;">
            <p style="margin: 0in 0in 0pt; text-align: center;"><b style="mso-bidi-font-weight: normal;">Variable Name</b></p>
            </td>
            <td style="background: #b8cce4; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; width: 231.15pt; height: 14.1pt; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-background-themecolor: accent1; mso-background-themetint: 102;">
            <p style="margin: 0in 0in 0pt; text-align: center;"><b style="mso-bidi-font-weight: normal;">Analyte Description</b></p>
            </td>
            <td style="background: #b8cce4; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; width: 90.55pt; height: 14.1pt; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-background-themecolor: accent1; mso-background-themetint: 102;">
            <p style="margin: 0in 0in 0pt; text-align: center;"><b style="mso-bidi-font-weight: normal;">LLOD</b></p>
            </td>
        </tr>
        <tr style="height: 13.15pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
            <td style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; width: 116.6pt; height: 13.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 0pt; text-align: center;">LBXHSCRP</p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 231.15pt; height: 13.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 0pt; text-align: center;">High
            Sensitivity C-Reactive Protein (mg/L)</p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 90.55pt; height: 13.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 0pt; text-align: center;">0.15</p>
            </td>
        </tr>
    </tbody>
</table>
</div>
<br />
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>High Sensitivity
C-Reactive Protein (HSCRP) regression equations to compare 2017-2018 and 2015-2016
data: </b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Method validation
(bridging) studies were performed to compare results from a laboratory,
instrument, and method change between the 2015-2016 and 2017-2018 survey cycles
using NHANES samples from late 2016.&nbsp;
During the 2015-2016 cycle the Beckman Coulter UniCel DxC 800 Synchron was
upgraded to the Beckman Coulter UniCel DxC 660i Synchron Access chemistry
analyzer (DxC 660i).&nbsp; Previous analyses
indicated that no statistical adjustment is needed for results obtained
between the two Beckman UniCel&reg; analyzers (i.e., DxC 800 and DxC 660i).&nbsp; During the 2017-2018
cycle the Roche Cobas 6000 chemistry analyzer (Cobas 6000) was used for the entire
2017-2018 cycle.&nbsp; Analyses comparing results obtained from the Cobas 6000 to those obtained
from the DxC 660i using selected serum samples (n=207) from NHANES participants
in 2016 indicate that adjustments are needed for some analytes as described
below. Statistical analyses were performed using Analyse-it, v4.30.4.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">On average, HSCRP
values measured with the Cobas 6000 (2017-2018 instrument) were 19.6% lower
than values measured with the DxC 660i (2015-2016 instrument) (n=207, p&lt;.0001)
and the correlation coefficient (r) between the measurements was 0.997.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Data from the
bridging study showed mixed difference in variability between measurement
procedures. For samples with HSCRP levels equal to or less than 20 mg/L based
on Cobas 6000 (or 23 mg/L based on DxC 660i) proportional differences were
observed and a weighted Deming regression was chosen to describe the relation
between the two instruments The equations are given below:</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><span style="text-decoration: underline;">Forward
(applicable to <i style="mso-bidi-font-style: normal;">DxC 660i</i> values &le; 23
mg/L) </span>:&nbsp;<b>Y</b> <i>(Cobas 6000)</i> <b>= 0.8695</b>
(95%CI: 0.8419 to 0.8971) <b>* X</b> <i>(</i><i style="mso-bidi-font-style: normal;">DxC 660i)</i> <b>+ 0.2954</b>
(95%CI: 0.2786 to 0.3121)</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><span style="text-decoration: underline;">Backward
(applicable to <i style="mso-bidi-font-style: normal;">Cobas
6000</i> values &le; 20 mg/L)</span>: <b>Y</b> (DxC 660i<i>)</i> <b>= 1.150 </b>(95%CI:
1.114 to 1.186) <b>* X</b> <i>(Cobas 6000)</i> <b>&ndash; 0.3397</b> (95%CI: -0.3663
to -0.3130)</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">For HSCRP levels
above 20 mg/L based on Cobas 6000 (or 23 mg/L based on DxC 660i), the
relationship between the two instruments appeared opposite that of the lower
values, with 2017-2018 measurements higher than 2015-2016 measurements.
However, with limited specimens within this range (n=7), we do not have enough
statistical power to recommend an adjustment for these results. </p>
<p style="margin: 0in 0in 10pt 0.5in; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2;">The regression equations derived from the bridging study are recommended when
examining trends of high sensitivity CRP data across 2015-2016 and 2017-2018
cycles. For data points above the specified range (i.e., <i style="mso-bidi-font-style: normal;">Cobas 6000</i> value &gt; 20 mg/L or <i style="mso-bidi-font-style: normal;">DxC 660i</i> value &gt; 23 mg/L), unadjusted values should be used with
caution. For analysis involving HSCRP data from the NHANES 2015-2016 cycle,
please refer to the documentation accompanying the 2015-2016 HSCRP data <a href="https://wwwn.cdc.gov/Nchs/Nhanes/2015-2016/HSCRP_I.htm"><span style="color: #003399;">(HSCRP_I)</span></a><span style="font-family: Calibri;"> </span>for additional
details.</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent Sequence Number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent Sequence Number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent Sequence Number</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHSCRP">LBXHSCRP - HS C-Reactive Protein (mg/L)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHSCRP</dd>
            <dt>SAS Label: </dt>
            <dd>HS C-Reactive Protein (mg/L)</dd>
            <dt>English Text: </dt>
            <dd class="info">High-Sensitivity C-Reactive Protein (hs-CRP) (mg/L)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0.11 to 182.82</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">7250</td>
                <td class="values" align="right">7250</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1116</td>
                <td class="values" align="right">8366</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHRPLC">LBDHRPLC - HS C-Reactive Protein Comment Code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHRPLC</dd>
            <dt>SAS Label: </dt>
            <dd>HS C-Reactive Protein Comment Code</dd>
            <dt>English Text: </dt>
            <dd class="info">High-Sensitivity C-Reactive Protein (hs-CRP) Comment Code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above detection limit</td>
                <td class="values" align="right">7175</td>
                <td class="values" align="right">7175</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">75</td>
                <td class="values" align="right">7250</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1116</td>
                <td class="values" align="right">8366</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>